10/5/2023 | DD | Lucira Health’s Chapter 11 liquidation plan effective as of Oct. 4
|
9/22/2023 | DD | Lucira Health reports $2.77 million net profit for August
|
9/21/2023 | DD | Lucira Health seeks post-confirmation exclusivity extension
|
9/19/2023 | DD | Lucira Health receives confirmation of Chapter 11 liquidation plan
|
9/15/2023 | DD | Lucira Health’s plan accepted by general unsecured creditor class
|
8/25/2023 | DD | Lucira Health reports $10.03 million net profit for July
|
7/31/2023 | DD | Lucira Health receives interim approval of disclosure statement
|
7/26/2023 | DD | Lucira Health reports $39.57 million net loss for June
|
7/11/2023 | DD | Lucira Health receives extension of exclusive plan periods
|
6/22/2023 | DD | Lucira seeks exclusivity extension, committee objects to plan
|
6/8/2023 | DD | Lucira files Chapter 11 plan of liquidation and disclosure statement
|
6/2/2023 | DD | Lucira Health creditors object to appointment of equity committee
|
5/24/2023 | DD | Lucira Health reports $23.25 million net profit for April
|
4/26/2023 | DD | Lucira Health reports $5.73 million net loss for March
|
4/21/2023 | DD | Lucira Health closes sale of its assets to winning bidder Pfizer
|
4/19/2023 | DD | Lucira Health gets bankruptcy court approval to sell assets to Pfizer
|
4/18/2023 | DD | Lucira names Pfizer winning bidder again after reopened auction
|
4/11/2023 | DD | Lucira’s auction process was ‘tainted and unfair,’ Pearsanta says
|
4/10/2023 | DD | Lucira Health names Pfizer winning bidder for assets
|
3/27/2023 | DD | Lucira Health receives court approval of bid procedures for assets
|
3/8/2023 | DD | Lucira Health’s official committee of unsecured creditors appointed
|
2/24/2023 | DD | Lucira Health sets bid procedures as it searches for stalking horse
|
2/22/2023 | DD | Lucira Health files Chapter 11 bankruptcy with plans to sell business
|